HBM4EU Diisocyanates Study-Research Protocol for a Collaborative European Human Biological Monitoring Study on Occupational Exposure

• Main Author: Jones, Kate
• Publication Date: 2022
• Other Authors: Galea, Karen S., Scholten, Bernice, Loikala, Marika, Porras, Simo P., Bousoumah, Radia, Ndaw, Sophie, Leese, Elizabeth, Louro, Henriqueta, Silva, Maria João, Viegas, Susana, Godderis, Lode, Verdonck, Jelle, Poels, Katrien, Gӧen, Thomas, Duca, Radu-Corneliu, Santonen, Tiina, HBM4EU Diisocyanates Study Team
• Format: Article
• Language: eng
• Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
• Download full: http://hdl.handle.net/10400.18/8371
• topic: Environmental Genotoxicity; Human Biomonitoring; Occupational Exposure; Diisocyanates; Biomarkers; Exposure Assessment; Workers; Genotoxicidade Ambiental

Diisocyanates have long been a leading cause of occupational asthma in Europe, and recently, they have been subjected to a restriction under the REACH regulations. As part of the European Human Biomonitoring project (HBM4EU), we present a study protocol designed to assessoccupational exposure to diisocyanates in five European countries. The objectives of the study are to assess exposure in a number of sectors that have not been widely reported on in the past (for example, the manufacturing of large vehicles, such as in aerospace; the construction sector, where there are potentially several sources of exposure (e.g., sprayed insulation, floor screeds); the use of MDI-based glues, and the manufacture of spray adhesives or coatings) to test the usability of different biomarkers in the assessment of exposure to diisocyanates and to provide background data for regulatory purposes. The study will collect urine samples (analysed for diisocyanate-derived diamines and acetyl–MDI–lysine), blood samples (analysed for diisocyanate-specific IgE and IgG antibodies, inflammatory markers, and diisocyanate-specific Hb adducts for MDI), and buccal cells(micronucleus analysis) and measure fractional exhaled nitric oxide. In addition, occupational hygienemeasurements (air monitoring and skin wipe samples) and questionnaire data will be collected. The protocol is harmonised across the participating countries to enable pooling of data, leading to better and more robust insights and recommendations.